Intervertebral Disc Prolapse Clinical Trial
Official title:
Gabapentin vs. Pregabalin for Post Operative Pain in Lumbar Microdiscectomy: a Randomized Controlled Trial.
Verified date | April 2014 |
Source | Aga Khan University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Pakistan: Research Ethics Committee |
Study type | Interventional |
Pregabalin is claimed to have superior analgesic effect at lower doses and better
pharmacological profile as compared to gabapentin esp. in perioperative pain control after
major surgeries like intervertebral disc surgery.
The investigators found that pregabalin is equivalent to gabapentin for relief of
post-operative pain at a lower dose in patients undergoing intervertebral disc surgery.
Status | Completed |
Enrollment | 78 |
Est. completion date | October 2011 |
Est. primary completion date | October 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 30 Years to 60 Years |
Eligibility |
Inclusion Criteria: - 30-60 years age - Any gender - elective micro discectomy for intervertebral disc prolapse Exclusion Criteria: 1. micro discectomy at two or more vertebral levels, 2. Instrumentation i.e. pedicle screw fixation, hooks etc., 3. history of steroids or alcohol use, 4. Multiple co-morbids i.e. renal failure, chronic liver disease, 5. use of anticonvulsant drugs, 6. Spinal deformity, 7. Obesity (BMI >30), 8) inability to understand and respond VAS and 9) patients with known allergy to GABA analogues. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
Pakistan | The Aga Khan University Hospital | Karachi | Sind |
Lead Sponsor | Collaborator |
---|---|
Aga Khan University |
Pakistan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain | Pain measurement using Visual Analogue Score at 24 hours and 7th day of surgery | 7 days | No |